KWC/H Knowlton Capital

LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec

LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec

MONTREAL, July 15, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF)  

LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded  Trichomed Corporation (Trichomed), its long awaited license to cultivate cannabis seeds and plants at its newly constructed facility in Brownsburg, Quebec. 

As per the terms of its agreement with Trichomed, LGC is, now entitled to convert the first ranking secured loan  it provided to Trichomed in December 2017 into  a 49% direct equity interest, and a five percent (5%) royalty of Trichomed’s net sales of cannabis and cannabis-related prodcuts which covers actual sales less any arm’s length third-party discounts, merchandise returns and rebates.  In addition as per the agreement, LGC is entitled to representation on Trichomed’s board.

For further information, please contact:

John McMullen, President

Tel: (416) 803-0698

Mark Shinners, Chief Financial Officer

Tel:

Renmark Financial Communications Inc.

Melanie Barbeau:

Media – Kellie Coppin:

Tel: (416) 644-2020 or (514) 939-3989

Caution Regarding Press Releases

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Statements

This press release may contain forward-looking statements with respect to LGC and their respective operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s most recent Discussion and Analysis  filed on SEDAR (). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and neither LGC nor Freia has any obligation to update such statements, except to the extent required by applicable securities laws.  Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

EN
15/07/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Knowlton Capital

 PRESS RELEASE

LGC Capital Ltd. Announces Name Change to Elixxer Ltd.

LGC Capital Ltd. Announces Name Change to Elixxer Ltd. MONTRÉAL, July 30, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) is pleased to announce that the TSX Venture Exchange (the “TSX-V”) has conditionally approved the change of name of the Corporation to Elixxer Ltd.  The name change was approved by the Corporation’s shareholders at the annual and special meeting held on May 22, 2019 (see press release dated May 23, 2019). The Corporation expects the name change to become effective at the opening of markets on Tuesday, August 6, 2019.  The Corporation will trade und...

 PRESS RELEASE

EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval

EU GMP Facility for EVOLUTION BNK Moves to Next Stage of Approval MONTREAL, July 24, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) LGC is pleased to announce that Evolution BNK’s Italian certifying consultants Studio Sannino S.a.s  have advised that Evolution BNK has now received its ISO 9001:2015 Certification for Production, processing, marketing of products derived from Industrial hemp for its Pavia facility in Italy. The following certification processes are now proceeding and under review from the relevant authorities: Agricultural sector certificat...

 PRESS RELEASE

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NE...

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl NEWSFLASH MONTRÉAL, July 22, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG and OTC-QB: LGGCF) (“LGC”) is pleased to announce that it has paid the 2nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). Freia () was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed fo...

 PRESS RELEASE

LGC Capital Ltd. Announces Change in Financial Year-End

LGC Capital Ltd. Announces Change in Financial Year-End MONTRÉAL, July 16, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) wishes to announce that it is changing its financial year-end to December 31 from its current year-end of September 30.  As a result, LGC will file an additional interim report as at September 30, 2019 and will report audited financial results for a 15-month transition year from October 1, 2018 to December 31, 2019 (with a comparative of the 12 months ended September 30, 2018). Afterwards, LGC will revert to a customary reporting calendar based on...

 PRESS RELEASE

LGC Capital, Ltd., announces Trichomed received its cultivation licens...

LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec MONTREAL, July 15, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF)   LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded  Trichomed Corporation (Trichomed), its long awaited license to cultivate cannabis seeds and plants at its newly constructed facility in Brownsburg, Quebec.  As per the terms of its agreement with Trichomed, LGC is, now entitled to convert the first ranking secured...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch